Topical Dermatologic Bioequivalence Methods May Vary According To Class
Executive Summary
Topical dermatological drug product bioequivalence methods may vary according to product classes, FDA Division of Dermatologic & Dental Drug Products Director Jonathan Wilkin, MD, told the Pharmaceutical Science Advisory Committee March 12